If a supplied lot fails agreed specifications, we’ll replace it at no cost or refund its purchase price in full.
Quality test failed? Free replacement or full refund.
Off-spec? Free replacement or full refund.
FDA PCAC reviews 7 peptides for the 503A bulks list (BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, Epitalon). Read our compounder's decision tree. Read our briefing →
FDA PCAC reviews 7 peptides for the 503A bulks list in July. Read →
FDA PCAC: 7 peptides under review. Read →
Release Documentation
A compounding pharmacy is not buying powder — it is buying a lot it can release into a patient preparation. So the documentation comes first here: what ships with the lot, the specification it was dispositioned against, and how it maps to the standard you file under.


Released-batch vials · Shanghai facility · post-QA hold
Quality You Can Verify
Ask sales for the COA matched to the offered or supplied batch. It records the tests actually completed. Route-specific methods, raw data, and independent reports are separate agreed scopes.
≥99%
Purity by HPLC
100%
Per-batch COA
<24h
Doc response
Batch COA available from sales for the relevant lot.
LAL endotoxin + microbial limits for sterile compounding-pharmacy use.
ICH Q1A stability, accelerated (40°C / 75% RH) + long-term data on request.
Published Certificates
These are certificate previews. Ask sales for the batch COA matched to the offered or supplied lot; it shows the tests completed and the reported results.
VerifiedRequest full COA →Tirzepatide
VD260428-TR216 · 99.32%
VerifiedRequest full COA →Retatrutide
VD260428-RT170 · 99.33%
VerifiedRequest full COA →Semaglutide
VD260428-SM177 · 99.45%
VerifiedRequest full COA →BPC-157
VD260428-BC10035 · 98.94%
VerifiedRequest full COA →TB-500 (Thymosin Beta-4, full-length)
VD260428-TB10195 · 98.88%
VerifiedRequest full COA →MOTS-c (Human)
VD260428-MS10139 · 99.48%
VerifiedRequest full COA →GHK-Cu
VD260428-CU100078 · 99.22%
VerifiedRequest full COA →CagriSema
VD260428-CS20039 · 99.17%
VerifiedRequest full COA →NAD+
VD260428-NJ1000145 · 99.27%
VerifiedRequest full COA →GLOW (BPC+GHK-Cu+TB)
VD260428-GLOW70084 · 99.27%
VerifiedRequest full COA →KLOW (BPC+GHK-Cu+TB+KPV)
VD260428-KLOW80119 · 99.19%
VerifiedRequest full COA →Ipamorelin
VD260428-IPA10116 · 99.53%
Third-party analytical reports
Independent HPLC and mass-spectrometry reports from Qorix , the professional, authoritative third-party analytical laboratory at tjqxgd.com, affiliated with the Tianjin International Joint Academy of Biomedicine.
Preview reports for eight of the most-requested matched products.
Third-party testView report record →Retatrutide
50 mg · HPLC / MS
RT50-20260814S6492
Third-party testView report record →BPC-157
10 mg · HPLC / MS
BC10-20260806S9397
Third-party testView report record →TB-500 / Thymosin beta-4
10 mg · HPLC / MS
TB10-20260810S7175
Third-party testView report record →MOTS-C
10 mg · HPLC / MS
MS10-20260810S6595
Third-party testView report record →BPC-157 + TB-500
5 + 5 mg · HPLC / MS
BB10-20260810S7175
Third-party testView report record →CJC-1295 + Ipamorelin
5 + 5 mg · HPLC / MS
CJCIPA510-20260814S6492
Third-party testView report record →SS-31
50 mg · HPLC / MS
SS50-20260806S9397
Third-party testView report record →KPV
10 mg · HPLC / MS
KP10-20260810S6595
Batch documentation
Tell us which product and report you need. Sales will confirm the matching batch or report number and provide the available full-resolution document.
If your qualification process requires a report issued by Janoshik, contact our sales team before quotation to confirm whether testing can be arranged, including the analytical scope, turnaround time, and cost.
What arrives with the lot
Ask sales for the Certificate of Analysis corresponding to the lot offered or shipped. It records the tests performed, applicable specifications, and results for that lot. Raw chromatograms, spectra, stability data, sequence verification, endotoxin, microbial limits, residual-solvent statements, and SDS documents are provided when included in the agreed analytical and documentation scope.
Per-lot record of HPLC purity, MS identity and any other tests performed, with applicable specifications and reported results; available from sales for the lot offered or shipped.
Bacterial endotoxin result when included in the agreed analytical scope.
GC-headspace result against agreed ICH Q3C limits when required for the lot.
Raw trace showing the main peak and the impurity profile behind the COA purity figure.
Raw ESI-MS spectrum behind the COA identity result (molecular mass within ±0.5 Da of theoretical).
Accelerated (40 °C / 75 % RH) and long-term real-time data supporting the assigned re-test date.
Independently verified amino-acid sequence for peptides longer than 15 aa.
Safety data sheet for handling and storage in your facility.
Qualification attributes
The attributes below are a qualification map, not a promise that every method applies to every product. The matching batch COA states what was actually completed; route-specific or expanded work must be agreed before quotation.
| Quality attribute | Method | Acceptance criterion |
|---|---|---|
| HPLC purity | Method stated on the applicable batch COA | Per agreed lot specification |
| Identity | Method stated on the applicable batch COA | Per agreed lot specification |
| Peptide content | When included in the agreed scope | Per agreed lot specification |
| Water content | When included in the agreed scope | Per agreed lot specification |
| Counter-ion | When included in the agreed scope | Per agreed lot specification |
| Bacterial endotoxin | Route-specific; agree before quotation | Per agreed lot specification |
| Microbial limits | Route-specific; agree before quotation | Per agreed lot specification |
| Residual solvents | When included in the agreed scope | Per agreed lot specification |
The offered lot's COA and the signed order scope are authoritative. Buyer-requested independent testing is optional and buyer-funded unless otherwise agreed in writing.
Mapped to your filing
Each signal below is a documentation posture Vialdyne can back with an artifact a qualified buyer can audit. They are worded to map onto the framework you compound under — USP <797> / <800> for a 503A pharmacy, ICH Q1A stability and DMF / ASMF support for a 503B program, EU GMP Annex 1 for an EU compounder. The lot data is the same; the wrapper matches your filing.
Qualifying a lot
Review the sample COA, confirm your QA requirements, and agree the supply terms. Each supplied lot can be traced to its matching batch COA.
Send your catalogue request with your license class. We return a representative COA, the endotoxin / bioburden spec, and an ICH stability summary so your QA team can review the format before any material moves.
Receive a sample lot and request its batch COA from sales. Reconcile the recorded results against your acceptance criteria; any incoming-material testing required by your own SOP remains optional and is not a Vialdyne condition of purchase.
We agree the release specification and the documentation wrapper that matches your filing — 503A, 503B, EU Annex 1, or distributor — under mutual NDA / supply terms.
For repeat orders, ask sales to confirm the current lot and provide its matching COA. Any additional documents remain governed by the written order scope, and documentation questions are handled through the regulatory / sales review.
First response under 24 hours · Catalog · Sample COA · MOQ · Lead time. Our regulatory and sales teams review every inquiry before pricing — license verification on every request.